urinari
tract
infect
uti
involv
colon
invas
bacteria
tissu
urinari
tract
infect
human
influenc
gender
age
common
young
women
uropathogen
escherichia
coli
upec
bacteria
often
origin
fece
microorgan
overcom
host
immun
system
abl
colon
lower
urinari
tract
establish
infect
infect
caus
upec
usual
selflimit
rare
spread
beyond
urethra
howev
upec
bacteria
invad
bladder
epitheli
cell
intracellular
amplif
upon
exit
cell
surfac
invad
epitheli
cell
tissu
bladder
establish
persist
infect
due
urinari
flow
mucu
secretori
iga
secret
bactericid
properti
urin
epitheli
cell
urinari
tract
normal
steril
howev
strain
e
coli
bacteria
grow
urinari
tract
owe
sever
share
virul
factor
adhes
molecul
toxin
earli
step
colon
upec
strain
mucos
surfac
host
depend
adhes
molecul
pili
dr
famili
adhesin
pili
p
pili
type
among
type
p
pili
consid
import
believ
upec
bacteria
establish
uti
presenc
papg
possibl
promot
progress
infect
sever
form
call
pyelonephr
current
treatment
acut
uti
limit
due
increas
rate
antibioticresist
strain
well
advers
effect
vaccin
sever
vaccin
candid
test
clinic
trial
uti
human
suitabl
result
obtain
date
therefor
design
new
strategi
vaccin
develop
lead
increas
vaccin
efficaci
varieti
studi
shown
adsorpt
vaccin
candid
antigen
surfac
bacteri
cell
use
deliveri
system
base
live
bacteri
vector
strongli
stimul
immun
respons
number
studi
indic
addit
nonpathogen
lactic
acid
bacteria
act
probiot
signific
posit
effect
variou
aspect
immun
system
immunemodul
also
increas
immun
respons
lactobacillu
reuteri
wellknown
probiot
exhibit
potent
immunomodulatori
effect
immun
respons
present
studi
l
reuteri
use
host
deliv
vaccin
antigen
immunogen
form
vaccin
candid
papg
anchor
surfac
l
reuteri
via
acma
use
linker
surfac
display
system
vaccin
evalu
uti
hypothes
present
papg
protein
cell
surfac
l
reuteri
make
vaccin
immunogen
therebi
immun
system
may
stimul
effect
papg
gene
segment
contain
histidin
tag
design
synthes
bioneer
clone
pexa
vector
bioneer
deajeon
korea
ndeibamhi
restrict
enzym
site
recombin
pexa
vector
transform
e
coli
cell
use
calcium
chlorid
method
plasmid
purif
carri
transform
bacteria
bioneer
purifi
plasmid
digest
ndei
bamhi
fermenta
vilniu
lithuania
isol
papg
gene
segment
ligat
vector
confirm
whether
vector
contain
papg
gene
segment
recombin
plasmid
doubl
digest
ndei
bamhi
enzym
electrophoresi
carri
agaros
gel
final
fidel
vector
confirm
gene
sequenc
macrogen
institut
seoul
south
korea
bind
papg
protein
surfac
l
reuteri
acma
anchor
protein
link
papg
protein
papgacma
fusion
segment
contain
histidin
tag
pexa
vector
ndeiecori
site
purchas
bioneer
pexapapgacma
vector
digest
ndeiecori
enzym
papgacma
segment
ligat
vector
fidel
papgacma
vector
confirm
use
ndeibamhi
enzymat
digest
sequenc
macrogen
institut
new
cultur
e
coli
origami
strain
start
recombin
vector
transform
use
standard
calcium
chlorid
protocol
express
recombin
papg
papgacma
protein
bacteria
contain
plasmid
induc
hour
use
mm
iptg
protein
express
confirm
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
recombin
papg
papgacma
protein
confirm
western
blot
use
antihi
antibodi
express
papg
papgacma
host
sdspage
perform
separ
protein
base
molecular
weight
subsequ
band
transfer
nitrocellulos
membran
trisglycin
buffer
contain
methanol
unbound
membran
site
block
trisbuff
salin
bovin
serum
albumin
tbsbsa
contain
tween
membran
wash
three
time
tbst
incub
histag
antibodi
horseradish
peroxidas
conjug
roch
mannheim
germani
hour
afterward
membran
wash
incub
dab
substrat
solut
contain
h
deep
brown
band
appear
membran
wash
distil
water
e
coli
cell
express
recombin
protein
centrifug
cell
pellet
suspend
buffer
mm
trishcl
nacl
triton
mm
pmsf
mm
imidazol
ph
sonic
cycl
second
mse
london
uk
suspens
centrifug
rpm
minut
sampl
load
ninta
column
qiagen
valencia
ca
usa
purif
perform
accord
manufactur
standard
protocol
protein
refold
carri
urea
dialysi
purifi
sampl
concentr
protein
detect
via
bradford
method
endotoxin
level
purifi
papg
papgacma
detect
limulu
amoebocyt
lysat
lal
test
accord
manufactur
standard
protocol
thermo
scientif
waltham
usa
bind
recombin
papg
fusion
protein
ligand
surfac
l
reuteri
carri
use
acma
protein
anchor
briefli
papgacma
volum
mix
lactobacillu
incub
hour
centrifug
rpm
minut
pellet
gentli
wash
three
time
pb
obtain
suspens
enabl
papg
display
surfac
l
reuteri
bind
recombin
papgacma
fusion
protein
surfac
bacteria
examin
enzymelink
immunosorb
assay
elisa
briefli
elisa
plate
coat
overnight
l
reuteri
display
papgacma
untreat
l
reuteri
neg
control
coat
plate
block
pbsbsa
hour
anti
histag
monoclon
antibodi
ad
well
plate
incub
hour
wash
time
dilut
antimous
horseradish
peroxidas
conjug
antibodi
ad
minut
plate
wash
tmb
sigma
st
loui
mo
usa
substrat
ad
well
reaction
stop
minut
absorb
measur
nm
use
elisa
auto
reader
elisa
carri
bacteria
store
day
construct
papg
vector
doubl
digest
recombin
plasmid
perform
use
ndeibamhi
ndeiecor
restrict
enzym
vector
respect
result
agaros
gel
electrophoresi
digest
plasmid
show
band
bp
bp
papgacma
papg
gene
segment
respect
figur
addit
result
sequenc
confirm
gene
segment
vector
data
shown
e
coli
origami
strain
use
express
recombin
papg
papgacma
protein
transform
express
mm
iptg
induct
sdspage
indic
overexpress
papg
approxim
kda
papgacma
approxim
kda
protein
figur
addit
western
blot
analysi
anti
histag
antibodi
show
band
approxim
kda
kda
papg
papgacma
protein
respect
figur
ninta
column
use
purifi
recombin
protein
purif
papg
papgacma
protein
sdspage
analysi
band
papg
band
papgacma
observ
minim
contamin
undesir
protein
figur
base
lal
test
purifi
recombin
papg
papgacma
protein
endotoxin
level
less
euml
surfac
display
papg
protein
confirm
elisa
consid
linkag
papg
protein
histag
antibodi
histag
use
detect
papg
protein
surfac
l
reuteri
elisa
result
surfacedisplay
papg
comparison
untreat
bacteria
show
signific
absorb
rel
control
sampl
day
storag
elisa
analysi
papg
protein
surfac
bacteria
indic
slight
decreas
optic
densiti
od
especi
day
storag
suggest
stabl
surfac
display
papg
protein
l
reuteri
figur
elisa
result
papg
display
surfac
l
reuteri
versu
untreat
l
reuteri
reveal
od
surfacedisplay
l
reuteri
higher
neg
control
indic
presenc
papg
surfac
l
reuteri
escherichia
coli
remain
one
common
bacteria
isol
variou
human
infect
uti
mening
sepsi
escherichia
coli
type
p
one
import
agent
uti
worldwid
accord
variou
report
uti
occurr
higher
women
children
elderli
immunocompromis
patient
men
bind
process
upec
facilit
type
p
fimbria
unlik
type
fimbria
mainli
caus
infect
lower
urinari
tract
system
p
fimbria
lead
ascend
infect
urinari
tract
basi
sever
kidney
infect
pyelonephr
numer
studi
focus
uti
antibiot
wellknown
method
reduc
prevent
acut
urinari
infect
develop
effect
vaccin
specif
infect
anoth
possibl
strategi
sinc
bind
step
import
colon
infect
process
inhibit
bacteri
bind
would
effect
strategi
wide
varieti
vaccin
focu
inhibit
bacteri
bind
via
distinct
target
molecul
present
studi
recombin
protein
papg
critic
adhes
molecul
involv
pathogenesi
bacteria
express
variou
studi
shown
papg
play
critic
role
attach
occurr
infect
inhibit
molecul
significantli
inhibit
pyelonephr
infect
therefor
hypothes
use
l
reuteri
combin
vaccin
modul
immun
respons
increas
vaccin
potenc
fact
stimul
innat
immun
system
toll
like
receptor
l
reuteri
provid
milieu
lymphocyt
abl
recogn
papg
inflammatori
condit
increas
immunogen
form
furthermor
l
reuteri
act
inhibitor
pathogen
bacteria
isol
women
bacteri
vaginosi
therefor
benefici
effect
uti
light
recombin
protein
papg
first
produc
confirm
use
sdspage
western
blot
immunogen
form
papg
display
surfac
l
reuteri
purpos
acma
protein
use
anchor
molecul
mani
studi
shown
acma
link
protein
surfac
lactobacillu
spp
therefor
acma
protein
use
linker
molecul
studi
link
molecul
surfac
l
reuteri
papg
protein
fuse
gene
level
produc
papgacma
act
fusion
protein
linkag
papg
surfac
l
reuteri
sever
studi
shown
acma
suitabl
linker
ligat
variou
protein
surfac
lactobacillu
sp
herein
papgacma
fusion
protein
purifi
incub
l
reuteri
bacteria
bind
level
protein
surfac
lactobacillu
cell
examin
elisa
recombin
protein
display
cell
surfac
suggest
strain
use
competit
inhibitor
agent
upec
anim
experi
elisa
analysi
papg
protein
surfac
l
reuteri
show
od
relat
papg
protein
surfac
l
reuteri
decreas
day
storag
sampl
store
day
show
slight
decreas
result
show
papg
vaccin
candid
surfac
display
strategi
suitabl
stabil
storag
minimum
one
month
immun
sever
studi
confirm
stabil
vaccin
surfac
display
system
consist
result
variou
studi
conduct
present
antigen
surfac
bacteria
lactobacillu
sp
helicobact
pylori
ureas
subunit
b
gene
e
fragment
anchor
sequenc
staphylococcu
aureu
spax
clone
express
vector
express
promot
l
lacti
confirm
western
blot
analysi
first
report
surfac
present
system
use
lactic
acid
bacteria
provid
oral
vaccin
h
pylori
jiankui
et
al
present
e
coli
pgsa
antigen
surfac
l
casei
antigen
display
confirm
immunoblot
immunofluoresc
flow
cytometri
addit
oral
administr
surfacedisplay
lactobacillu
mice
caus
increas
secretori
iga
titer
protect
effect
experiment
challeng
present
studi
produc
l
reuteri
bacteria
display
papg
protein
vaccin
candid
studi
intend
evalu
efficaci
vaccin
murin
model
show
effect
vaccin
candid
immunolog
paramet
well
protect
effect
experiment
challeng
